People with early-stage Hodgkin lymphoma face a higher risk of dying from cardiovascular disease than from cancer
North Korea pushes traditional medicine to fight COVID-19
25 July 2022Study shows link between frequent naps and high blood pressure
25 July 2022People with early-stage Hodgkin lymphoma face a higher risk of dying from cardiovascular disease than from cancer
Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer that affects the lymphatic system—but therapies can increase patients’ risk of developing heart problems. A recent study published by Wiley online in CANCER reveals that people with early-stage HL are now at higher risk of dying from cardiovascular disease than from cancer.
